Altogether, all the pieces of evidence demonstrate an important role of IL-18 in severe forms of respiratory diseases and the pertinency of anti-IL-1R7 in treating IL-18-mediated respiratory inflammation. This evidence concerns the gene IL18RAP and respiratory system disorder.